Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19.3M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
+456K
-
Total reported value, excl. options
-
$2.09B
-
Value change
-
+$57.1M
-
Put/Call ratio
-
0.45
-
Number of buys
-
86
-
Number of sells
-
-102
-
Price
-
$131.19
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2021
251 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q2 2021.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 19.3M outstanding shares and own 82.58% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.04M shares), VANGUARD GROUP INC (1.52M shares), JANUS HENDERSON GROUP PLC (1.44M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.25M shares), STATE STREET CORP (859K shares), VILLERE ST DENIS J & CO LLC (594K shares), MACQUARIE GROUP LTD (594K shares), Chicago Capital, LLC (459K shares), Conestoga Capital Advisors, LLC (441K shares), and DIMENSIONAL FUND ADVISORS LP (409K shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.